問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
蘇柏嵐
下載
2020-05-18 - 2023-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2019-06-01 - 2025-12-31
Participate Sites3Sites
Recruiting3Sites
2020-09-15 - 2026-10-01
Participate Sites4Sites
Recruiting4Sites
2022-03-09 - 2026-12-15
2022-05-10 - 2026-06-30
Not yet recruiting1Sites
Recruiting5Sites
2022-11-30 - 2027-10-31
Participate Sites9Sites
Recruiting9Sites
2020-03-01 - 2023-12-31
Participate Sites2Sites
Recruiting2Sites
2018-08-01 - 2026-12-01
Recruiting8Sites
2020-06-01 - 2022-02-09
Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
AMG 510
2020-09-01 - 2023-09-20
Advanced Solid Tumors
ASP1951
Division of Hematology & Oncology
全部
